Tirzepatide lowered risk of worsening heart failure and CVD death for obese adults
In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking ...
Benzinga.com18h
Eli Lilly's Zepbound/Mounjaro Shows Cardiovascular Benefits In Patients With Obesity-Related Heart Failure
Also Read: 99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years ... tirzepatide saw a nearly 25-point ...
News Medical on MSN15h
Tirzepatide improves heart health and function in obese HFpEF patients
In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...
FoodNavigator-Asia49m
High dietary intake of magnesium and fibre mitigates risk of metabolic syndrome among Kuwaiti women – study
Data on dietary intake were collected using a modified Semi-Quantitative Food Frequency Questionnaire (SFFQ), which covered .
pharmaphorum17h
Tirzepatide gets a big win in obesity-related heart failure
"Obesity contributes to worsening heart failure, and while tirzepatide causes considerable weight loss, research is lacking ...